All In MedTech

Device Trial Radar · NCT04130737

The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study

The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2

Last checked: Nov 20, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

188

Actual

Start

Aug 13, 2018

Primary completion

Jan 6, 2023

Study completion Feb 14, 2025

Sponsor

Lead sponsor
EndologixNot on our public-company list
Sponsor type
Industry
Collaborators
Syntactx; PQ Bypass, Inc.
First posted
Oct 17, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

Conditions

  • Peripheral Arterial Disease

Interventions

  • TORUS Stent Graft SystemDevice

    The TORUS Stent Graft is an intravascular prosthesis intended to improve blood flow in the area in which it is implanted and the TORUS Stent Graft Delivery System is a standard pin-and-pull delivery system used to implant the SG in the desired area. Use of the TORUS Stent Graft allows for improving blood flow in the peripheral vasculature.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom From a Major Adverse Event (MAE)Time frame: 30 days
  2. Primary PatencyTime frame: 12 months

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • Southwest CVA

    Mesa, Arizona

  • Vascular Heart & Lung Associates

    Mesa, Arizona

  • Phoenix Cardiovascular Research Group

    Phoenix, Arizona

29 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.